38
Participants
Start Date
November 30, 2011
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
Metronidazole
Metronidazole will be administered at a dose of 500 mg TID (or QID for refractory or severe infection) for 3 to 14 days, in principle. Treatment duration can be prolonged up to 21 days based on subject's condition.
Ceftriaxone sodium
Ceftriaxone sodium will be administered at a daily dose of 2 g (strength) when metronidazole is administered TID or at a daily dose of 4 g (strength) when metronidazole is administered QID.
Daiyukai First Hospital, Ichinomiya
Hirosaki National Hospital, Hirosaki
National Hospital Organization Chiba Medical Center, Chiba
National Hospital Organization Kokura Medical Center, Kitakyushu
National Hospital Organization Fukuyama Medical Center, Fukuyama
Hitachi General Hospital, Hitachi
Kawasaki Saiwai Hospital, Kawasaki
Kumamoto Saishunso National Hospital, Koushi
National Hospital Organization Kumamoto Medical Center, Kumamoto
National Hospital Organization Sendai Medical Center, Sendai
Iida Municipal Hospital, Iida
Nagano Prefectural Suzaka Hospital, Suzaka-shi
National Hospital Organization Nagasaki Medical Center, Ohmura
National Hospital Organization Osaka Minami Medical Center, Kawachi-Nagano
Koshigaya Municipal Hospital, Koshigaya
Lead Sponsor
Pfizer
INDUSTRY